drug · Product Intelligence

Psilocybin
Pipeline Intelligence

Psilocybin: 8 indexed trials, 8 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
8Indexed trials
▦
8Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT04718792Anders Fink-Jensen, MD, DMSci · substance_usePHASE2
NCT05399498University of Chicago · depressionPHASE2
NCT05554094Ohio State University · ptsdPHASE2
NCT06368492Maastricht University · pain_neuropathyNA
NCT06529939Western University, Canada · other_psychiatryNA
NCT07169747Region Skane · eating_disordersPHASE2
NCT07332143Emory University · ptsdPHASE2
NCT07721467National Institute on Aging (NIA) · alzheimersPHASE2

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.